Dosimetric Benefits of Stereotactic MR-guided Adaptive Radiotherapy in Locally Advanced Pancreatic Cancers

Stereotactic MR-guided Adaptive Radiotherapy (SMART) is an attractive treatment for locally advanced pancreatic cancers (LAPC). Daily adaptation is compulsory to obtain these levels of dose escalation and guarantee OAR protection. The study objective was to evaluate the benefit of daily adaptive treatments on tumor coverage and organs at risk (OAR) doses with MR-Linac. Five consecutive LAPC patients treated at Institut du Cancer de Montpellier...